Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 33.76% is 120% above its 4-year average of 15.31%, near the high end of its 4-year range (-108.75%–35.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 13.76% above its 12-month average of 29.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 33.76%.
RETURN ON INVESTED CAPITAL (ROIC)
33.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
29.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
14.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
15.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-51.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-51.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+13.76%
CURRENT VS 3Y AVG
+135.36%
CURRENT VS 5Y AVG
+120.48%
CURRENT VS 10Y AVG
+165.75%
CURRENT VS 15Y AVG
+165.20%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+194.71%
vs the sector median at left
Nutex Health, Inc.
Market Cap
$1.53B
Return on Invested Capital (ROIC)
33.76%
TTM Avg
29.68%
3Y Avg
14.34%
5Y Avg
15.31%
Market Cap
$1.51B
Return on Invested Capital (ROIC)
20.41%
TTM Avg
-2.25%
3Y Avg
-13.09%
5Y Avg
-29.56%
Market Cap
$1.54B
Return on Invested Capital (ROIC)
-32.15%
TTM Avg
-60.15%
3Y Avg
-48.54%
5Y Avg
-35.53%
Market Cap
$1.54B
Return on Invested Capital (ROIC)
8.36%
TTM Avg
8.44%
3Y Avg
9.74%
5Y Avg
16.58%
Market Cap
$1.49B
Return on Invested Capital (ROIC)
11.91%
TTM Avg
9.57%
3Y Avg
7.02%
5Y Avg
7.35%
Market Cap
$1.57B
Return on Invested Capital (ROIC)
-63.12%
TTM Avg
-24.75%
3Y Avg
-38.52%
5Y Avg
-35.23%
Market Cap
$1.47B
Return on Invested Capital (ROIC)
-35.66%
TTM Avg
-26.24%
3Y Avg
-27.95%
5Y Avg
-27.95%
Market Cap
$1.47B
Return on Invested Capital (ROIC)
-19.87%
TTM Avg
-24.87%
3Y Avg
-20.19%
5Y Avg
-15.68%
Market Cap
$1.46B
Return on Invested Capital (ROIC)
-28.63%
TTM Avg
-6.26%
3Y Avg
-69.26%
5Y Avg
-69.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutex Health, Inc. (NUTX) | $1.53B | 33.76% | 29.68% | 14.34% | 15.31% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 20.41% | -2.25% | -13.09% | -29.56% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | -32.15% | -60.15% | -48.54% | -35.53% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 8.36% | 8.44% | 9.74% | 16.58% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 11.91% | 9.57% | 7.02% | 7.35% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -63.12% | -24.75% | -38.52% | -35.23% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | -35.66% | -26.24% | -27.95% | -27.95% |
| GH Research PLC (GHRS)vs › | $1.47B | -19.87% | -24.87% | -20.19% | -15.68% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | -28.63% | -6.26% | -69.26% | -69.26% |
| Certara, Inc. (CERT)vs › | $1.45B | 0.59% | 0.35% | -0.10% | -0.25% |
ROIC
33.8%
ROE
45.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 33.76% |
| 2026-03-31 | 26.89% |
| 2025-12-31 | 25.36% |
| 2025-09-30 | 35.21% |
| 2025-06-30 | 27.17% |
| 2025-03-31 | 26.95% |
| 2024-12-31 | 21.30% |
| 2024-09-30 | -2.53% |
| 2024-06-30 | -5.50% |
| 2024-03-31 | -7.26% |
| 2023-12-31 | -8.97% |
| 2023-09-30 | -0.25% |
| 2023-06-30 | -107.72% |
| 2023-03-31 | -108.75% |
| 2022-12-31 | -101.07% |
| 2022-09-30 | -95.63% |
| 2022-06-30 | 11.56% |
| 2021-12-31 | 30.68% |
| 2021-03-31 | 79.87% |
| 2020-12-31 | 20.31% |
| 2020-09-30 | -1470.55% |
| 2020-06-30 | -2673.37% |
| 2020-03-31 | -5840.62% |
| 2019-12-31 | -7367.89% |
| 2019-09-30 | -20511.18% |
| 2019-06-30 | -11102.07% |
| 2019-03-31 | -6025.80% |
| 2018-12-31 | -575.88% |
| 2018-09-30 | -450.82% |
| 2018-06-30 | -130.84% |
| 2018-03-31 | -60.33% |
| 2017-12-31 | 32.92% |
| 2011-12-31 | -47.33% |
| 2011-09-30 | -59.98% |
| 2011-06-30 | -58.89% |
| 2011-03-31 | -59.50% |
| 2010-12-31 | -67.90% |
